leadf
logo-loader
TSX:TBP

Tetra Bio-Pharma

Receive alerts
Market:
TSX
Market Cap:
$55.56 m
Price
0.16 CAD
Change
-8.82%
52 weeks high
0.37
52 weeks low
0.14

In brief

Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries that are engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Snapshot

Derived from cannabinoids, ARDS-003 is designed to prevent and treat acute respiratory distress syndrome, a severe inflammatory response that could be life-threatening to coronavirus patients